Who cares? Why do you always do the "What about Biden ?"

New Post Public Reply Private Reply Replies (4) Message Board
dw dbergh #106659
243
Who cares?
Why do you always do the "What about Biden ?" shit.
What about: Trump was given every opportunity to just return the secret documents! But he chose to say no so he must pay. LIke everybody else.
Why does TRump get a pass?
No sir. You are blind to what is going on.
Sad.
Meanwhile:Atop the list of legislative achievements is climate change. That's assuming the House of Representatives, over the coming days, passes, as expected, that Senate budget bill.

The so-called Inflation Reduction Act includes nearly $400 billion in tax credits and subsidies for a myriad of clean energy programs — from home retrofits, to electric vehicles, to clean utilities.

That's aside from non-legislative acts like Biden rejoining the Paris accord, buying zero-emission vehicles for the federal government, and an Arctic oil-drilling moratorium.

Infrastructure is another issue where Biden made headway. He took office planning to spend $2 trillion on infrastructure, for roads, bridges, public transit, rail, electric vehicles, electric car chargers, grid electrification, and rural broadband internet.

Numerous Republicans even voted to help him succeed where Trump failed: he signed a bill spending $1 trillion — of which an estimated $415 billion was new, previously unplanned, spending.

Bipartisan votes also helped pass a bill designed to give the U.S. a boost in its technological race with China, with $79 billion for research, advanced manufacturing, and semiconductor production. As he signed the bill Tuesday, Biden referred to a conversation he once had with the president of China, and vowed to protect U.S. manufacturing capability.
U.S. economy blows past expectations by adding 528,000 jobs in July
Bill with incentives for 'North American' electric vehicles passes in U.S. Senate.

I can go on but you dont read my posts anyway.....
tic tic tic
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading